Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
37 Leser
Artikel bewerten:
(0)

Global In-Vitro Diagnostics Market - Industry Forecast to 2025 - Analysis By Product, Application, Technology, End User & Geography

DUBLIN, August 23, 2017 /PRNewswire/ --

The "Global In-Vitro Diagnostics Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The Global In- vitro diagnostics market is poised to grow at a CAGR of around 5.7% over the next decade to reach approximately $95.96 billion by 2025. Some of the prominent trends that the market is witnessing are growing healthcare expenditure in the emerging markets, huge demand for technologically advanced testing methods, raising incidences of chronic disease and growth opportunities/investment opportunities.

Based on product the market is categorized into data management software, reagents & kits, instruments, software and services and consumables. By application the market is segmented into cancer, cardiac diseases, infectious disease, drug testing/pharmacogenomics, cardiology, diabetes, nephrology, HIV/AIDS, autoimmune diseases and other applications.

Depending on technology the market is segregated by Molecular Diagnostics (MDX), immunochemistry/immunoassays, clinical chemistry, clinical microbiology, coagulation and haemostasis, haematology and other IVD technologies. Furthermore molecular diagnostics (MDX) is segmented by polymerase chain reaction (PCR), hybridization, isothermal nucleic acid amplification technology (INAAT), microarray, DNA diagnostics and other MDX technologies.


Current Trends:

  • Growing Healthcare Expenditure in the Emerging Markets.
  • Huge Demand for Technologically Advanced Testing Methods.
  • Raising Incidences of Chronic Diseases.

Companies Mentioned

  • Johnson & Johnson
  • Sysmex Corporation
  • Biomérieux SA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Alere Inc.
  • Thermo Fisher Scientific, Inc.
  • Bristol-Myers Squibb Company
  • Abbott Laboratories, Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Diasorin S.P.A.
  • Bio-Rad Laboratories, Inc.
  • Siemens AG
  • Arkray, Inc.
  • Qiagen N.V.
  • Roche Diagnostics
  • Affymetrix Inc.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Global In- Vitro Daiagnostics Market, By Product

5 Global In Vitro Diagnostics Market, By Application

6 Global In Vitro Diagnostics Market, By Technology

7 Global In Vitro Diagnostics Market, By End-User

8 Global In Vitro Diagnostics Market, By Geography

For more information about this report visit https://www.researchandmarkets.com/research/nmrkxr/global_invitro

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.